Latest News and Press Releases
Want to stay updated on the latest news?
-
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular...
-
REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that the company will be webcasting its presentations at the following upcoming...
-
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- First Responders Children’s Foundation (FRCF), a national 501(c)(3) organization dedicated to serving the children of U.S. first responders including...
-
Daix (France), New York City (New York, Etats-Unis), le 27 mai 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le...
-
Daix (France), New York City (New York, United States), May 27, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on...
-
TEL AVIV, Israel, April 08, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventor of a new laser-based computing paradigm, today announced the appointment of financial and banking expert Colin Bell to its...
-
MONACO, April 08, 2025 (GLOBE NEWSWIRE) -- The Yacht Club de Monaco and UBS renew a partnership that goes far beyond simple sponsorship. It is a strategic alliance that has its roots in over thirty...
-
SAN ANTONIO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (Nasdaq: RXT), a leading end-to-end, hybrid, multicloud, and AI solutions company, today announced that Amar Maletira,...
-
SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
-
SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...